Insmed Yönetim
Yönetim kriter kontrolleri 3/4
Insmed CEO'su Will Lewis, Sep2012 tarihinde atandı, in görev süresi 12.17 yıldır. in toplam yıllık tazminatı $ 10.41M olup, şirket hissesi ve opsiyonları dahil olmak üzere 7.5% maaş ve 92.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.25% ine doğrudan sahiptir ve bu hisseler $ 32.89M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5 yıl ve 10.5 yıldır.
Anahtar bilgiler
Will Lewis
İcra Kurulu Başkanı
US$10.4m
Toplam tazminat
CEO maaş yüzdesi | 7.5% |
CEO görev süresi | 12.2yrs |
CEO sahipliği | 0.3% |
Yönetim ortalama görev süresi | 5yrs |
Yönetim Kurulu ortalama görev süresi | 10.5yrs |
Son yönetim güncellemeleri
Recent updates
Insmed: PAH Treatment Advancement With 2nd Half 2025 Top-Line Data
Nov 20Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up
Sep 12Insmed: Brensocatib Propels Stock As Regulatory Milestones Approach
Aug 28Is Insmed (NASDAQ:INSM) A Risky Investment?
Aug 10Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up
May 29Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)
May 28Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Feb 25Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected
Dec 18Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely
Jul 28Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)
Jul 01Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?
Apr 18A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)
Feb 23Insmed inks financing agreements to raise $500M
Oct 19Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?
Oct 17An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued
Sep 20Insmed rises 16% on better-than-expected Q2 result
Aug 04CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$864m |
Jun 30 2024 | n/a | n/a | -US$803m |
Mar 31 2024 | n/a | n/a | -US$747m |
Dec 31 2023 | US$10m | US$780k | -US$750m |
Sep 30 2023 | n/a | n/a | -US$724m |
Jun 30 2023 | n/a | n/a | -US$696m |
Mar 31 2023 | n/a | n/a | -US$547m |
Dec 31 2022 | US$8m | US$735k | -US$482m |
Sep 30 2022 | n/a | n/a | -US$434m |
Jun 30 2022 | n/a | n/a | -US$416m |
Mar 31 2022 | n/a | n/a | -US$438m |
Dec 31 2021 | US$7m | US$710k | -US$435m |
Sep 30 2021 | n/a | n/a | -US$424m |
Jun 30 2021 | n/a | n/a | -US$375m |
Mar 31 2021 | n/a | n/a | -US$319m |
Dec 31 2020 | US$6m | US$660k | -US$294m |
Sep 30 2020 | n/a | n/a | -US$245m |
Jun 30 2020 | n/a | n/a | -US$242m |
Mar 31 2020 | n/a | n/a | -US$247m |
Dec 31 2019 | US$7m | US$641k | -US$254m |
Sep 30 2019 | n/a | n/a | -US$293m |
Jun 30 2019 | n/a | n/a | -US$320m |
Mar 31 2019 | n/a | n/a | -US$330m |
Dec 31 2018 | US$6m | US$610k | -US$324m |
Sep 30 2018 | n/a | n/a | -US$298m |
Jun 30 2018 | n/a | n/a | -US$256m |
Mar 31 2018 | n/a | n/a | -US$224m |
Dec 31 2017 | US$4m | US$567k | -US$193m |
Tazminat ve Piyasa: Will 'ın toplam tazminatı ($USD 10.41M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 12.66M ).
Tazminat ve Kazançlar: Will şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Will Lewis (55 yo)
12.2yrs
Görev süresi
US$10,411,260
Tazminat
Mr. William H. Lewis, also known as Will, J.D. M.B.A. serves as an Independent Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January 2024. He has been Chief Executive Officer and...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 12.2yrs | US$10.41m | 0.25% $ 32.9m | |
Chief Financial Officer | 4.8yrs | US$4.56m | 0.010% $ 1.3m | |
Chief Operating Officer | 5yrs | US$4.01m | 0.036% $ 4.6m | |
Chief Commercial Officer | 5yrs | US$3.89m | 0.029% $ 3.8m | |
Chief Medical Officer | 4.9yrs | US$4.22m | 0.0071% $ 929.2k | |
Chief Scientific Officer | no data | Veri yok | Veri yok | |
Associate Director of Investor Relations | no data | Veri yok | Veri yok | |
Chief Legal Officer & Corporate Secretary | 3.3yrs | Veri yok | 0.038% $ 5.0m | |
Executive Director of Corporate Communications | no data | Veri yok | Veri yok | |
Chief People Strategy Officer | 11.8yrs | US$2.66m | 0.019% $ 2.5m | |
Chief Product Strategy Officer | 7.5yrs | US$1.69m | Veri yok | |
GM & Head of Europe | 5.4yrs | Veri yok | Veri yok |
5.0yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: INSM 'un yönetim ekibi deneyimli ve deneyimlidir ( 5 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 12.2yrs | US$10.41m | 0.25% $ 32.9m | |
Independent Director | 11.1yrs | US$320.00k | 0.048% $ 6.3m | |
Independent Director | 23.5yrs | US$312.50k | 0.18% $ 23.8m | |
Independent Director | 12.3yrs | US$320.00k | 0.031% $ 4.1m | |
Lead Independent Director | 10.5yrs | US$345.00k | 0.061% $ 8.0m | |
Independent Director | 5yrs | US$315.00k | 0.027% $ 3.6m | |
Independent Director | 6yrs | US$310.00k | 0.031% $ 4.1m | |
Independent Director | 6.5yrs | US$317.50k | 0.062% $ 8.2m | |
Independent Director | 4.6yrs | US$315.00k | 0.025% $ 3.3m |
10.5yrs
Ortalama Görev Süresi
65yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: INSM 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 10.5 yıldır).